Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells

被引:0
|
作者
Yanli Bi
Longyuan Gong
Pengyuan Liu
Xiufang Xiong
Yongchao Zhao
机构
[1] Zhejiang University School of Medicine,Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital
[2] Zhejiang University School of Medicine,Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital
[3] Zhejiang University School of Medicine,Institute of Translational Medicine
[4] Zhejiang University School of Medicine,Cancer Institute of the Second Affiliated Hospital
[5] Cancer Center,undefined
[6] Zhejiang University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
ErbB2, a classical receptor tyrosine kinase, is frequently overexpressed in breast cancer cells. Although the role of ErbB2 in the transmission of extracellular signals to intracellular matrix has been widely studied, the functions of nuclear ErbB2 remain largely elusive. Here, we report a novel function of nuclear ErbB2 in repressing the transcription of DEPTOR, a direct inhibitor of mTOR. Nuclear ErbB2 directly binds to the consensus binding sequence in the DEPTOR promoter to repress its transcription. The kinase activity of ErbB2 is required for its nuclear translocation and transcriptional repression of DEPTOR. Moreover, the repressed DEPTOR by nuclear ErbB2 inhibits the induction of autophagy by activating mTORC1. Thus, our study reveals a novel mechanism for autophagy regulation by functional ErbB2, which translocates to the nucleus and acts as a transcriptional regulator to suppress DEPTOR transcription, leading to activation of the PI3K/AKT/mTOR pathway to inhibit autophagy.
引用
收藏
相关论文
共 50 条
  • [31] In Vitro Selection of RNA Aptamer and Specific Targeting of ErbB2 in Breast Cancer Cells
    Kim, Mee Young
    Jeong, Sunjoo
    NUCLEIC ACID THERAPEUTICS, 2011, 21 (03) : 173 - 178
  • [32] ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells
    Lindsay, Jaime
    Jiao, Xuanmao
    Sakamaki, Toshiyuki
    Casimiro, Mathew C.
    Shirley, Lawrence A.
    Tran, Thai H.
    Ju, Xiaoming
    Liu, Manran
    Li, Zhiping
    Wang, Chenguang
    Katiyar, Sanjay
    Rao, Mahadev
    Allen, Kathleen G.
    Glazer, Robert I.
    Ge, Changhui
    Stanley, Pamela
    Lisanti, Michael P.
    Rui, Hallgeir
    Pestell, Richard G.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2008, 1 (02): : 107 - 115
  • [33] ETHANOL ENHANCES THE INTERACTION OF BREAST CANCER CELLS OVEREXPRESSING ERBB2 WITH EXTRACELLULAR MATRIX
    Luo, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 265A - 265A
  • [34] Phosphoproteome of signaling by ErbB2 in ovarian cancer cells
    Sidhanth, C.
    Bindhya, S.
    Krishnapriya, S.
    Manasa, P.
    Shabna, A.
    Alifia, J.
    Patole, C.
    Kumar, V
    Garg, M.
    Ganesan, T. S.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2022, 1870 (04):
  • [35] Brk is coamplified with ErbB2 to promote proliferation in breast cancer
    Xiang, Bin
    Chatti, Kiranam
    Qiu, Haoqun
    Lakshmi, B.
    Krasnitz, Alexander
    Hicks, Jim
    Yu, Min
    Miller, W. Todd
    Muthuswamy, Senthil K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (34) : 12463 - 12468
  • [36] MiR-34a modulates ErbB2 in breast cancer
    Wang, Yilin
    Zhang, Xiaolong
    Chao, Zou
    Kung, Hsiang-Fu
    Lin, Marie C.
    Dress, Andreas
    Wardle, Fiona
    Jiang, Bing-Hua
    Lai, Lihui
    CELL BIOLOGY INTERNATIONAL, 2017, 41 (01) : 93 - 101
  • [37] The ErbB2 signaling network as a target for breast cancer therapy
    Badache, Ali
    Goncalves, Anthony
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2006, 11 (01) : 13 - 25
  • [38] The potential role of the EGFR/ERBB2 heterodimer in breast cancer
    Cicenas, Jonas
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (06) : 607 - 616
  • [39] The ErbB2 Signaling Network as a Target for Breast Cancer Therapy
    Ali Badache
    Anthony Gonçalves
    Journal of Mammary Gland Biology and Neoplasia, 2006, 11 : 13 - 25
  • [40] Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores
    Robbins, Charles J. J.
    Fernandez, Aileen I. I.
    Rimm, David L. L.
    JAMA ONCOLOGY, 2023, 9 (09) : 1298 - 1299